Global Intravenous Injection Immunoglobulin Market Growth 2023-2029

February 2023 | 93 pages | ID: GEF11B1E8B68EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Intravenous Injection Immunoglobulin Industry Forecast” looks at past sales and reviews total world Intravenous Injection Immunoglobulin sales in 2022, providing a comprehensive analysis by region and market sector of projected Intravenous Injection Immunoglobulin sales for 2023 through 2029. With Intravenous Injection Immunoglobulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Injection Immunoglobulin industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Injection Immunoglobulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Injection Immunoglobulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intravenous Injection Immunoglobulin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Injection Immunoglobulin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Injection Immunoglobulin.

The global Intravenous Injection Immunoglobulin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Intravenous Injection Immunoglobulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Intravenous Injection Immunoglobulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Intravenous Injection Immunoglobulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Intravenous Injection Immunoglobulin players cover Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB and Nanyue Biopharming, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Injection Immunoglobulin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 1g/20ml
• 1.25g/25ml
• 2.5g/50ml
• 5g/100ml
• 10g/200ml

Segmentation by application

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Boya-Bio
• Beijing Tiantan Biological Products
• Hualan Bio
• Guangdong Shuagnlin Bio-pharmacy
• Weiguang Biological
• Sinopharm
• Shanghai RAAS
• CTBB
• Nanyue Biopharming

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravenous Injection Immunoglobulin market?

What factors are driving Intravenous Injection Immunoglobulin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravenous Injection Immunoglobulin market opportunities vary by end market size?

How does Intravenous Injection Immunoglobulin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intravenous Injection Immunoglobulin Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Intravenous Injection Immunoglobulin by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Intravenous Injection Immunoglobulin by Country/Region, 2018, 2022 & 2029
2.2 Intravenous Injection Immunoglobulin Segment by Type
  2.2.1 1g/20ml
  2.2.2 1.25g/25ml
  2.2.3 2.5g/50ml
  2.2.4 5g/100ml
  2.2.5 10g/200ml
2.3 Intravenous Injection Immunoglobulin Sales by Type
  2.3.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2018-2023)
  2.3.2 Global Intravenous Injection Immunoglobulin Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Intravenous Injection Immunoglobulin Sale Price by Type (2018-2023)
2.4 Intravenous Injection Immunoglobulin Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Intravenous Injection Immunoglobulin Sales by Application
  2.5.1 Global Intravenous Injection Immunoglobulin Sale Market Share by Application (2018-2023)
  2.5.2 Global Intravenous Injection Immunoglobulin Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Intravenous Injection Immunoglobulin Sale Price by Application (2018-2023)

3 GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN BY COMPANY

3.1 Global Intravenous Injection Immunoglobulin Breakdown Data by Company
  3.1.1 Global Intravenous Injection Immunoglobulin Annual Sales by Company (2018-2023)
  3.1.2 Global Intravenous Injection Immunoglobulin Sales Market Share by Company (2018-2023)
3.2 Global Intravenous Injection Immunoglobulin Annual Revenue by Company (2018-2023)
  3.2.1 Global Intravenous Injection Immunoglobulin Revenue by Company (2018-2023)
  3.2.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Company (2018-2023)
3.3 Global Intravenous Injection Immunoglobulin Sale Price by Company
3.4 Key Manufacturers Intravenous Injection Immunoglobulin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Intravenous Injection Immunoglobulin Product Location Distribution
  3.4.2 Players Intravenous Injection Immunoglobulin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR INTRAVENOUS INJECTION IMMUNOGLOBULIN BY GEOGRAPHIC REGION

4.1 World Historic Intravenous Injection Immunoglobulin Market Size by Geographic Region (2018-2023)
  4.1.1 Global Intravenous Injection Immunoglobulin Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Intravenous Injection Immunoglobulin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Intravenous Injection Immunoglobulin Market Size by Country/Region (2018-2023)
  4.2.1 Global Intravenous Injection Immunoglobulin Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Intravenous Injection Immunoglobulin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Intravenous Injection Immunoglobulin Sales Growth
4.4 APAC Intravenous Injection Immunoglobulin Sales Growth
4.5 Europe Intravenous Injection Immunoglobulin Sales Growth
4.6 Middle East & Africa Intravenous Injection Immunoglobulin Sales Growth

5 AMERICAS

5.1 Americas Intravenous Injection Immunoglobulin Sales by Country
  5.1.1 Americas Intravenous Injection Immunoglobulin Sales by Country (2018-2023)
  5.1.2 Americas Intravenous Injection Immunoglobulin Revenue by Country (2018-2023)
5.2 Americas Intravenous Injection Immunoglobulin Sales by Type
5.3 Americas Intravenous Injection Immunoglobulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intravenous Injection Immunoglobulin Sales by Region
  6.1.1 APAC Intravenous Injection Immunoglobulin Sales by Region (2018-2023)
  6.1.2 APAC Intravenous Injection Immunoglobulin Revenue by Region (2018-2023)
6.2 APAC Intravenous Injection Immunoglobulin Sales by Type
6.3 APAC Intravenous Injection Immunoglobulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Intravenous Injection Immunoglobulin by Country
  7.1.1 Europe Intravenous Injection Immunoglobulin Sales by Country (2018-2023)
  7.1.2 Europe Intravenous Injection Immunoglobulin Revenue by Country (2018-2023)
7.2 Europe Intravenous Injection Immunoglobulin Sales by Type
7.3 Europe Intravenous Injection Immunoglobulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intravenous Injection Immunoglobulin by Country
  8.1.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Intravenous Injection Immunoglobulin Revenue by Country (2018-2023)
8.2 Middle East & Africa Intravenous Injection Immunoglobulin Sales by Type
8.3 Middle East & Africa Intravenous Injection Immunoglobulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Injection Immunoglobulin
10.3 Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
10.4 Industry Chain Structure of Intravenous Injection Immunoglobulin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Intravenous Injection Immunoglobulin Distributors
11.3 Intravenous Injection Immunoglobulin Customer

12 WORLD FORECAST REVIEW FOR INTRAVENOUS INJECTION IMMUNOGLOBULIN BY GEOGRAPHIC REGION

12.1 Global Intravenous Injection Immunoglobulin Market Size Forecast by Region
  12.1.1 Global Intravenous Injection Immunoglobulin Forecast by Region (2024-2029)
  12.1.2 Global Intravenous Injection Immunoglobulin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Injection Immunoglobulin Forecast by Type
12.7 Global Intravenous Injection Immunoglobulin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Boya-Bio
  13.1.1 Boya-Bio Company Information
  13.1.2 Boya-Bio Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Boya-Bio Main Business Overview
  13.1.5 Boya-Bio Latest Developments
13.2 Beijing Tiantan Biological Products
  13.2.1 Beijing Tiantan Biological Products Company Information
  13.2.2 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Beijing Tiantan Biological Products Main Business Overview
  13.2.5 Beijing Tiantan Biological Products Latest Developments
13.3 Hualan Bio
  13.3.1 Hualan Bio Company Information
  13.3.2 Hualan Bio Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.3.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Hualan Bio Main Business Overview
  13.3.5 Hualan Bio Latest Developments
13.4 Guangdong Shuagnlin Bio-pharmacy
  13.4.1 Guangdong Shuagnlin Bio-pharmacy Company Information
  13.4.2 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Guangdong Shuagnlin Bio-pharmacy Main Business Overview
  13.4.5 Guangdong Shuagnlin Bio-pharmacy Latest Developments
13.5 Weiguang Biological
  13.5.1 Weiguang Biological Company Information
  13.5.2 Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Weiguang Biological Main Business Overview
  13.5.5 Weiguang Biological Latest Developments
13.6 Sinopharm
  13.6.1 Sinopharm Company Information
  13.6.2 Sinopharm Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.6.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Sinopharm Main Business Overview
  13.6.5 Sinopharm Latest Developments
13.7 Shanghai RAAS
  13.7.1 Shanghai RAAS Company Information
  13.7.2 Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.7.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Shanghai RAAS Main Business Overview
  13.7.5 Shanghai RAAS Latest Developments
13.8 CTBB
  13.8.1 CTBB Company Information
  13.8.2 CTBB Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.8.3 CTBB Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 CTBB Main Business Overview
  13.8.5 CTBB Latest Developments
13.9 Nanyue Biopharming
  13.9.1 Nanyue Biopharming Company Information
  13.9.2 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolios and Specifications
  13.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Nanyue Biopharming Main Business Overview
  13.9.5 Nanyue Biopharming Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Intravenous Injection Immunoglobulin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Intravenous Injection Immunoglobulin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 1g/20ml
Table 4. Major Players of 1.25g/25ml
Table 5. Major Players of 2.5g/50ml
Table 6. Major Players of 5g/100ml
Table 7. Major Players of 10g/200ml
Table 8. Global Intravenous Injection Immunoglobulin Sales by Type (2018-2023) & (L)
Table 9. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2018-2023)
Table 10. Global Intravenous Injection Immunoglobulin Revenue by Type (2018-2023) & ($ million)
Table 11. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2018-2023)
Table 12. Global Intravenous Injection Immunoglobulin Sale Price by Type (2018-2023) & (US$/ml)
Table 13. Global Intravenous Injection Immunoglobulin Sales by Application (2018-2023) & (L)
Table 14. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2018-2023)
Table 15. Global Intravenous Injection Immunoglobulin Revenue by Application (2018-2023)
Table 16. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2018-2023)
Table 17. Global Intravenous Injection Immunoglobulin Sale Price by Application (2018-2023) & (US$/ml)
Table 18. Global Intravenous Injection Immunoglobulin Sales by Company (2018-2023) & (L)
Table 19. Global Intravenous Injection Immunoglobulin Sales Market Share by Company (2018-2023)
Table 20. Global Intravenous Injection Immunoglobulin Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Intravenous Injection Immunoglobulin Revenue Market Share by Company (2018-2023)
Table 22. Global Intravenous Injection Immunoglobulin Sale Price by Company (2018-2023) & (US$/ml)
Table 23. Key Manufacturers Intravenous Injection Immunoglobulin Producing Area Distribution and Sales Area
Table 24. Players Intravenous Injection Immunoglobulin Products Offered
Table 25. Intravenous Injection Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Intravenous Injection Immunoglobulin Sales by Geographic Region (2018-2023) & (L)
Table 29. Global Intravenous Injection Immunoglobulin Sales Market Share Geographic Region (2018-2023)
Table 30. Global Intravenous Injection Immunoglobulin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Intravenous Injection Immunoglobulin Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Intravenous Injection Immunoglobulin Sales by Country/Region (2018-2023) & (L)
Table 33. Global Intravenous Injection Immunoglobulin Sales Market Share by Country/Region (2018-2023)
Table 34. Global Intravenous Injection Immunoglobulin Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Intravenous Injection Immunoglobulin Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Intravenous Injection Immunoglobulin Sales by Country (2018-2023) & (L)
Table 37. Americas Intravenous Injection Immunoglobulin Sales Market Share by Country (2018-2023)
Table 38. Americas Intravenous Injection Immunoglobulin Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Intravenous Injection Immunoglobulin Revenue Market Share by Country (2018-2023)
Table 40. Americas Intravenous Injection Immunoglobulin Sales by Type (2018-2023) & (L)
Table 41. Americas Intravenous Injection Immunoglobulin Sales by Application (2018-2023) & (L)
Table 42. APAC Intravenous Injection Immunoglobulin Sales by Region (2018-2023) & (L)
Table 43. APAC Intravenous Injection Immunoglobulin Sales Market Share by Region (2018-2023)
Table 44. APAC Intravenous Injection Immunoglobulin Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Intravenous Injection Immunoglobulin Revenue Market Share by Region (2018-2023)
Table 46. APAC Intravenous Injection Immunoglobulin Sales by Type (2018-2023) & (L)
Table 47. APAC Intravenous Injection Immunoglobulin Sales by Application (2018-2023) & (L)
Table 48. Europe Intravenous Injection Immunoglobulin Sales by Country (2018-2023) & (L)
Table 49. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2018-2023)
Table 50. Europe Intravenous Injection Immunoglobulin Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country (2018-2023)
Table 52. Europe Intravenous Injection Immunoglobulin Sales by Type (2018-2023) & (L)
Table 53. Europe Intravenous Injection Immunoglobulin Sales by Application (2018-2023) & (L)
Table 54. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Country (2018-2023) & (L)
Table 55. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Intravenous Injection Immunoglobulin Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Type (2018-2023) & (L)
Table 59. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Application (2018-2023) & (L)
Table 60. Key Market Drivers & Growth Opportunities of Intravenous Injection Immunoglobulin
Table 61. Key Market Challenges & Risks of Intravenous Injection Immunoglobulin
Table 62. Key Industry Trends of Intravenous Injection Immunoglobulin
Table 63. Intravenous Injection Immunoglobulin Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Intravenous Injection Immunoglobulin Distributors List
Table 66. Intravenous Injection Immunoglobulin Customer List
Table 67. Global Intravenous Injection Immunoglobulin Sales Forecast by Region (2024-2029) & (L)
Table 68. Global Intravenous Injection Immunoglobulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Intravenous Injection Immunoglobulin Sales Forecast by Country (2024-2029) & (L)
Table 70. Americas Intravenous Injection Immunoglobulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Intravenous Injection Immunoglobulin Sales Forecast by Region (2024-2029) & (L)
Table 72. APAC Intravenous Injection Immunoglobulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Intravenous Injection Immunoglobulin Sales Forecast by Country (2024-2029) & (L)
Table 74. Europe Intravenous Injection Immunoglobulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Intravenous Injection Immunoglobulin Sales Forecast by Country (2024-2029) & (L)
Table 76. Middle East & Africa Intravenous Injection Immunoglobulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Intravenous Injection Immunoglobulin Sales Forecast by Type (2024-2029) & (L)
Table 78. Global Intravenous Injection Immunoglobulin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Intravenous Injection Immunoglobulin Sales Forecast by Application (2024-2029) & (L)
Table 80. Global Intravenous Injection Immunoglobulin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Boya-Bio Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 82. Boya-Bio Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 83. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 84. Boya-Bio Main Business
Table 85. Boya-Bio Latest Developments
Table 86. Beijing Tiantan Biological Products Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 87. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 88. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 89. Beijing Tiantan Biological Products Main Business
Table 90. Beijing Tiantan Biological Products Latest Developments
Table 91. Hualan Bio Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 92. Hualan Bio Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 93. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 94. Hualan Bio Main Business
Table 95. Hualan Bio Latest Developments
Table 96. Guangdong Shuagnlin Bio-pharmacy Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 97. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 98. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 99. Guangdong Shuagnlin Bio-pharmacy Main Business
Table 100. Guangdong Shuagnlin Bio-pharmacy Latest Developments
Table 101. Weiguang Biological Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 102. Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 103. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 104. Weiguang Biological Main Business
Table 105. Weiguang Biological Latest Developments
Table 106. Sinopharm Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 107. Sinopharm Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 108. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 109. Sinopharm Main Business
Table 110. Sinopharm Latest Developments
Table 111. Shanghai RAAS Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 112. Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 113. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 114. Shanghai RAAS Main Business
Table 115. Shanghai RAAS Latest Developments
Table 116. CTBB Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 117. CTBB Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 118. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 119. CTBB Main Business
Table 120. CTBB Latest Developments
Table 121. Nanyue Biopharming Basic Information, Intravenous Injection Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 122. Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolios and Specifications
Table 123. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue ($ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 124. Nanyue Biopharming Main Business
Table 125. Nanyue Biopharming Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Intravenous Injection Immunoglobulin
Figure 2. Intravenous Injection Immunoglobulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Injection Immunoglobulin Sales Growth Rate 2018-2029 (L)
Figure 7. Global Intravenous Injection Immunoglobulin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Intravenous Injection Immunoglobulin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 1g/20ml
Figure 10. Product Picture of 1.25g/25ml
Figure 11. Product Picture of 2.5g/50ml
Figure 12. Product Picture of 5g/100ml
Figure 13. Product Picture of 10g/200ml
Figure 14. Global Intravenous Injection Immunoglobulin Sales Market Share by Type in 2022
Figure 15. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2018-2023)
Figure 16. Intravenous Injection Immunoglobulin Consumed in Hospital
Figure 17. Global Intravenous Injection Immunoglobulin Market: Hospital (2018-2023) & (L)
Figure 18. Intravenous Injection Immunoglobulin Consumed in Clinic
Figure 19. Global Intravenous Injection Immunoglobulin Market: Clinic (2018-2023) & (L)
Figure 20. Intravenous Injection Immunoglobulin Consumed in Others
Figure 21. Global Intravenous Injection Immunoglobulin Market: Others (2018-2023) & (L)
Figure 22. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2022)
Figure 23. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application in 2022
Figure 24. Intravenous Injection Immunoglobulin Sales Market by Company in 2022 (L)
Figure 25. Global Intravenous Injection Immunoglobulin Sales Market Share by Company in 2022
Figure 26. Intravenous Injection Immunoglobulin Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Intravenous Injection Immunoglobulin Revenue Market Share by Company in 2022
Figure 28. Global Intravenous Injection Immunoglobulin Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Intravenous Injection Immunoglobulin Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Intravenous Injection Immunoglobulin Sales 2018-2023 (L)
Figure 31. Americas Intravenous Injection Immunoglobulin Revenue 2018-2023 ($ Millions)
Figure 32. APAC Intravenous Injection Immunoglobulin Sales 2018-2023 (L)
Figure 33. APAC Intravenous Injection Immunoglobulin Revenue 2018-2023 ($ Millions)
Figure 34. Europe Intravenous Injection Immunoglobulin Sales 2018-2023 (L)
Figure 35. Europe Intravenous Injection Immunoglobulin Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Intravenous Injection Immunoglobulin Sales 2018-2023 (L)
Figure 37. Middle East & Africa Intravenous Injection Immunoglobulin Revenue 2018-2023 ($ Millions)
Figure 38. Americas Intravenous Injection Immunoglobulin Sales Market Share by Country in 2022
Figure 39. Americas Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2022
Figure 40. Americas Intravenous Injection Immunoglobulin Sales Market Share by Type (2018-2023)
Figure 41. Americas Intravenous Injection Immunoglobulin Sales Market Share by Application (2018-2023)
Figure 42. United States Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Intravenous Injection Immunoglobulin Sales Market Share by Region in 2022
Figure 47. APAC Intravenous Injection Immunoglobulin Revenue Market Share by Regions in 2022
Figure 48. APAC Intravenous Injection Immunoglobulin Sales Market Share by Type (2018-2023)
Figure 49. APAC Intravenous Injection Immunoglobulin Sales Market Share by Application (2018-2023)
Figure 50. China Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country in 2022
Figure 58. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2022
Figure 59. Europe Intravenous Injection Immunoglobulin Sales Market Share by Type (2018-2023)
Figure 60. Europe Intravenous Injection Immunoglobulin Sales Market Share by Application (2018-2023)
Figure 61. Germany Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Application (2018-2023)
Figure 70. Egypt Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Intravenous Injection Immunoglobulin Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Intravenous Injection Immunoglobulin in 2022
Figure 76. Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
Figure 77. Industry Chain Structure of Intravenous Injection Immunoglobulin
Figure 78. Channels of Distribution
Figure 79. Global Intravenous Injection Immunoglobulin Sales Market Forecast by Region (2024-2029)
Figure 80. Global Intravenous Injection Immunoglobulin Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Intravenous Injection Immunoglobulin Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Intravenous Injection Immunoglobulin Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Intravenous Injection Immunoglobulin Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Intravenous Injection Immunoglobulin Revenue Market Share Forecast by Application (2024-2029)